Korro Bio (KRRO) vs Organigram Global (OGI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Organigram Global (OGI) has outperformed Korro Bio (KRRO) over the past year, losing 51.0% versus a loss of 78.5%. Over five years, OGI leads with a -89.3% price change compared with -97.0% for KRRO. Korro Bio is the larger company by market cap ($154.5 million vs $138.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRRO | OGI |
|---|---|---|
| Share price | $10.49 | $0.96 |
| Market cap | $154.47M | $138.39M |
| 1-day change | +7.48% | -1.04% |
| YTD return | +30.96% | -42.86% |
| 1-year return | -78.49% | -51.02% |
| 5-year return | -97.05% | -89.29% |
| P/E ratio (TTM) | — | 2.23 |
| Forward P/E | — | 40.00 |
| EPS (TTM) | $-10.62 | $0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.89 | $2.24 |
| 52-week low | $5.20 | $0.853 |
| Distance from 52-week high | -81.23% | -57.14% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +92.56% | — |
| Average volume | 148.67K | 891.72K |
| Shares outstanding | 14.73M | 144.15M |
| Employees | 57 | 1,139 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OGI has outperformed KRRO by 27.5 percentage points over the past year.
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Healthcare · Biotechnology · 57 employees
About Organigram Global
OGI stock →Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,139 employees
KRRO vs OGI FAQ
Which is bigger, Korro Bio or Organigram Global?
Korro Bio (KRRO) is larger, with a market capitalization of $154.47M compared with $138.39M for Organigram Global (OGI).
Which stock has performed better over the past year, KRRO or OGI?
OGI returned -51.02% over the past 12 months, compared with -78.49% for KRRO (price return, excluding dividends). Past performance does not predict future results.
Are Korro Bio and Organigram Global in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Korro Bio and Drug Manufacturers - Specialty & Generic for Organigram Global.